 following attempted conservative and/or endovenous therapies for superficial
refux. These patients usually have class C4b to C6 disease or disabling signs and symptoms
such as severe edema (C3) (Sidawy and Perler 2023e). Treatment options focus on either
correcting the anatomical defect of the incompetent valve via internal valvuloplasty/external
valvuloplasty, or by replacing the architecture via valve transposition or vein transplantation
